AzTrials
AzTrials

Respiratory FailurePhase 2NCT00142766

Sedation Management in Pediatric Patients Supported on Mechanical Ventilation

A Phase 2 study testing Nurse Implemented Goal-Directed Comfort Algorithm in people with Respiratory Failure, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at 3 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this two-year project is to pilot test an intervention to change sedation management in pediatric patients supported on mechanical ventilation for acute respiratory failure in the pediatric intensive care unit (PICU). Read more about this study

Who is it for?
Ages 2 weeks to 18 years
Conditions the study is for
Respiratory Failure
What is being tested?
Nurse Implemented Goal-Directed Comfort Algorithm
How many people
245 participants
Where
3 sitesUnited States
Study dates
Feb 2004to Mar 2007
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 weeks to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Intubated and mechanically ventilated
  • Pulmonary disease

Who cannot join

  • Less than or equal to 2 weeks of age or 42 weeks corrected gestational age
  • Greater than 18 years of age
  • Intubated and mechanically ventilated for immediate post-operative care and stabilization
  • Cyanotic heart disease with unrepaired or palliated right to left intracardiac shunt
  • Critical airway (e.g. post laryngotracheal reconstruction)
  • Ventilator dependent (including noninvasive) on PICU admission (chronic assisted ventilation)
Show all 12Show fewer
  • Neuromuscular respiratory failure
  • Spinal cord injury above the lumbar region
  • Managed by patient controlled analgesia (PCA)or epidural catheter
  • Known allergy to any of the study medications (Morphine,Methadone, Midazolam, Lorazepam)
  • Family/Medical team have decided not to provide full support(patient treatment considered futile)
  • Previously enrolled into the current study or enrolled in any other sedation clinical trial concurrently or within the last 30 days

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • Children's Hospital Boston

    Boston, Massachusetts, 02115

  • Children's Hospital of Wisconsin

    Milwaukee, Wisconsin, 53201

  • Children's National Medical Center

    Washington D.C., District of Columbia, 20010

Other trials in United States

About this study

The purpose of this two-year project is to pilot test an intervention to change sedation management in pediatric patients supported on mechanical ventilation for acute respiratory failure in the pediatric intensive care unit (PICU). While ensuring patient comfort is an integral part of pediatric critical care, analgesic and sedative use in this patient population is associated with injury; specifically, comfort medications may depress spontaneous ventilation and prolong the duration of mechanical ventilation. Additionally, drug tolerance develops over time and may precipitate iatrogenic abstinence syndrome (chemical withdrawal) when the patient no longer requires sedation. Alternatively, suboptimal comfort management contributes to the patient not breathing synchronously with the ventilator and/or self-removal of breathing tubes.

Our group has developed and validated a nurse-implemented sedation algorithm (set of specific instructions) to guide titration of comfort medications that may optimize patient comfort and reduce the risk of under-medication, but this algorithm needs to be evaluated further. We hypothesize that pediatric patients managed per sedation protocol will experience fewer days of mechanical ventilation than patients receiving usual care. This research has the potential of revolutionizing sedation practices that are driven by and synchronized to patient needs.

Read the detailed description

We propose a two-year project to pilot test and evaluate an intervention to change sedation management in pediatric patients supported on mechanical ventilation for acute respiratory failure in the PICU. Rather than seeking an elusive ideal drug, this unique nurse-led pilot study focuses on optimizing clinical decision making by: (a) multidisciplinary team education and consensus building; (b) multidisciplinary team identification of the patient's trajectory of illness and daily prescribing of a sedation goal; (c) a nurse-implemented sedation algorithm to guide titration of comfort medications; and(d)team feedback on clinical performance. This intervention models the most recent sedation clinical practice guideline published by the Society of Critical Care Medicine and addresses the only potentially manipulable factor influencing extubation failures rates in the Pediatric Intensive Care Unit.

The coordinating center, Children's Hospital Boston, developed, tested and currently uses the sedation algorithm as a standard of care. We will pilot the intervention in two separate previously selected PICUs that are matched on size and organization, academic affiliation and volume of patients supported on mechanical ventilation. One PICU will be randomized to receive early intervention while the other will first serve as a control, then will receive a delayed intervention.

The study design is a randomized controlled trial with delayed intervention in the control hospital. Because the intervention is an educational and organizational change directed at all PICU clinicians, the unit of randomization and analysis is the PICU. During the start-up phase, case report forms will be developed and a consensus meeting with all nurse and physician co-investigators will be conducted. The purpose of this consensus meeting will be to review the Children's Hospital Boston experience with the sedation algorithm and reach agreement on its application in the two PICUs. System nuances may impact protocol implementation and will require group discussion and multidisciplinary problem solving.

Study design includes baseline assessment of the organizational structure and comfort practices in both units. The PICU randomized to early intervention will then undergo training followed by implementation, a one-month respite, and post-data collection to evaluate the sustainability of the practice change. The PICU randomized to delayed intervention will start with pre-data collection, then undergo training followed by implementation. This design allows multiple comparisons; specifically, baseline to intervention/control, pre and post comparisons in both units, and sustainability in one unit.

Training will be multifaceted and will include all clinicians (physicians, nurses, clinical pharmacists and physicians-in-training) involved in the sedation management of intubated mechanically-ventilated patients. A multidisciplinary, cooperative approach is necessary to assure compliance and successful implementation of protocols. Training material will include discipline-specific lectures, informal discussions, video on sedation and opioid withdrawal scoring, bedside booklets, and physician order sheets. The research team will develop the supporting materials. Physician training will focus on sedation and opioid withdrawal scoring, identifying the patient's trajectory of illness, collaborating with nursing in prescribing the daily sedation goal, and completion of the standardized order template. Nursing content will likewise focus on sedation and opioid withdrawal scoring, trajectory analysis and collaboration, but also will include practical support on the daily "wake-up" test and titration of sedatives. Prior to the intervention phase, all physicians, physician-in-training, unit-based clinical pharmacist, charge nurses and full-time nursing staff will be required to document their understanding of the intervention by completion of a discipline-specific scenario-based self-assessment evaluation. Respiratory therapists will also require refresher instruction on extubation readiness testing and general information about sedation assessment and sedation algorithm.

During the implementation phase, daily multidisciplinary rounds will include identification of the patient's trajectory of illness and daily prescription of (a) sedation goal and (b) sedation parameters. Nurses will titrate the comfort medications as prescribed and perform a daily "wake up" test in patients during their stable phase who are not awake. During the implementation phase, a member of the research team will round separately on each patient to monitor for study compliance and offer staff support and re-training as necessary. This level of vigilance is necessary to identify aspects of the algorithm that are challenging to clinicians, and accurate reporting of protocol deviations requires an evaluation of the context of decision-making. This daily check will not continue in the early intervention arm when sustainability is evaluated. During the implementation phase, all sedation orders will be derived from standardized physician orders. This order template will serve two purposes: physician education and enhanced compliance with the algorithm

Being tested
Nurse Implemented Goal-Directed Comfort Algorithm
Keywords
Sedation, Mechanical ventilation, Critical illness, Analgesic, Opioid Withdrawal, Benzodiazepine Withdrawal, Nurse
Medical subject headings
Respiratory Insufficiency, Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nurse Implemented Goal-Directed Comfort AlgorithmBehavioural

    See description

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Duration of Mechanical Ventilation

    Measured: 28 days

Secondary outcomes (8)
  1. Time to Recovery of Lung Injury

    Measured: 28 days

  2. Duration of Weaning from Mechanical Ventilation

    Measured: 28 days

  3. Occurrence of Adverse Events

    Measured: 28 days

  4. Total Exposure to Comfort Medications

    Measured: 28 days

  5. Occurrence of Iatrogenic Abstinence Syndrome

    Measured: 28 days

  6. PICU Length of Stay

    Measured: 28 days

  7. Barriers to Successful Implementation of the Intervention

    Measured: 28 days

  8. PICU costs

    Measured: 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Sep 2005 (estimated)
  2. Study startFeb 2004
  3. Primary completionJul 2006
  4. Study completionMar 2007

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
245 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00142766
Sponsor's protocol ID
R21HD045020
Status last verified
Oct 2015
First submitted
31 Aug 2005
Last updated
7 Oct 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • Curley MAQ, Gedeit RG, Dodson BL, Amling JK, Soetenga DJ, Corriveau CO, Asario LA, Wypij D; RESTORE Investigative Team. Methods in the design and implementation of the Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) clinical trial. Trials. 2018 Dec 17;19(1):687. doi: 10.1186/s13063-018-3075-8.

    PubMed 30558653

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Nurse Implemented Goal-Directed Comfort Algorithm in people with Respiratory Failure, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Oct 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Duration of Mechanical Ventilation (time frame: 28 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00142766, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in